SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is at a critical inflection point as the community focuses on the upcoming launch of BlueBird 7 and the company's commitment to ramping up satellite production cadence to meet aggressive 2026 deployment targets. Investors are actively debating the impact of recent insider selling against the backdrop of significant contracted revenue and institutional backing, with sentiment split between those viewing current volatility as a strategic entry point and others expressing skepticism over execution risks.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing extreme volatility and intense community debate after a massive surge and subsequent sharp decline, with investors actively discussing potential market manipulation and the risks of holding tokens following accusations of a rug pull. The community remains deeply divided, with some traders hunting for a bounce while others warn of a total collapse and criticize the project's circulating supply structure.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors rally around Greenland's approval of the company's increased 92.5% stake in the Tanbreez rare earth deposit, a move many believe de-risks the asset and bolsters Western mineral supply chain security. The community is actively debating potential short squeeze dynamics and arguing that the current valuation fails to fully account for the project's strategic significance and long-term earnings potential.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly is experiencing significant market attention following its latest Phase 3 trial data for retatrutide, which demonstrated substantial weight loss and A1C reduction in type 2 diabetes patients without reaching a plateau. While the company's long-term dominance in the obesity and diabetes sector remains a core talking point, investors are closely monitoring competitive pressure from Novo Nordisk and regulatory scrutiny regarding potential safety profiles.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

Chainlink is garnering attention as the infrastructure layer for institutional finance, highlighted by the integration of SIX Group's massive real-time equities data onto the blockchain. The community is actively debating its role in RWA tokenization and its potential to serve as the critical bridge for TradFi, while concurrently navigating broader market volatility and speculation regarding future regulatory impacts.

The Doge Jones Industrial Average was created as a satirical take on traditional finance, drawing inspiration from the well-known Dow Jones Industrial Average. It serves as a humorous reflection on the seriousness of traditional financial systems, bringing the irreverence and unpredictability of meme culture into the world of finance. Unlike conventional assets, its utility revolves around its community by creating a culture poking fun at the idea of “market indices” by parodying them with internet culture.

Doge Jones Industrial Average

The index is at the center of intense debate as traders weigh geopolitical tensions and economic data against concerns of market volatility and potential recession. Community members remain sharply divided between those calling for a defensive posture due to valuation risks and those anticipating a year-end melt-up.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is trending following a presidential executive order designed to fast-track FDA reviews and expand research funding for psychedelic therapies. The community is actively discussing the stock's potential for clinical acceleration, with many focused on its status as one of the few players to successfully complete two Phase 3 trials and its positioning for upcoming regulatory catalysts.

The 401jK (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and the popular US based 401(k) retirement plan and other pension plans around the world  Through the meme fueled humor, irony, satire &amp; inspiration from cypherpunk ideology, real life data, and current events... the 401jK community aims to comment on the fact that global markets are heavily manipulated for selfish purposes by the same people who control these pension funds... while also aiming to twist the heads of the 401k and global pension systems.  It is a retirement plan that seeks to make social, political, economic commentary fueled by the memes and dreams of the hive mind of the community that makes up 401jK  The rules have changed, and the game was always rigged.  It's time to wake up, adapt, rebel, and heal.  Welcome to 401jK

401jK

The 401jK community is actively promoting a "resist and retire" narrative as a satirical protest against traditional financial systems, positioning their token as a grassroots alternative. While supporters highlight the project's longevity, staking mechanisms, and educational initiatives as signs of long-term conviction, critics dismiss the stock as a speculative pump-and-dump scheme prone to volatility.

BtcUSD is a completely decentralized stablecoin issued and managed by BTCFi, a platform where users can deposit Bitcoin of various formats to use as collaterals. BtcUSD offers Bitcoin holders the opportunity to generate additional yields with their Bitcoin positions through DeFi usage.

Bitcoin USD (BTCFi)

Bitcoin is currently trading near critical resistance levels, with the community actively debating whether it will break out toward new highs or face a deeper technical correction. Traders are closely monitoring key support zones and liquidity patterns as Bitcoin's performance continues to heavily influence sentiment across broader tech and crypto-related equities.

Daddy Darth Sidious

SIDIOUS is gaining traction alongside DARTH as part of a themed 'Daddy Darth' sector, with the community actively promoting these nano-cap tokens as speculative weekend runners. Investors are debating the risks of these low-liquidity assets while frequently rotating profits between related tokens in hopes of catching a breakout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Will Livmarli Continue to Aid Mirum's Top Line in Q1 Earnings?

MIRM heads into Q1 earnings with Livmarli sales in focus after 69% year-over-year growth in 2025. Bile acid products broaden revenue momentum.

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that on April 10, 2026, the Compensation Committee of Mirums Board of Directors granted inducement awards...

Tudor Investment Corp ET AL Takes $2.03 Million Position in Mirum Pharmaceuticals, Inc. $MIRM

Tudor Investment Corp ET AL bought a new stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with...

18,710 Shares in Mirum Pharmaceuticals, Inc. $MIRM Purchased by SG Americas Securities LLC

SG Americas Securities LLC acquired a new stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange...

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives Average Rating of "Moderate Buy" from Analysts

Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Get Free Report) have earned an average rating of "Moderate Buy" from the fourteen analysts that are covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, twelve have assigned a buy rat...

Mirum Pharmaceuticals (MIRM) Moves 5.1% Higher: Will This Strength Last?

Mirum Pharmaceuticals (MIRM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

JPMorgan Chase & Co. Sells 380,067 Shares of Mirum Pharmaceuticals, Inc. $MIRM

JPMorgan Chase & Co. lessened its holdings in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 79.1% during the third quarter, according to the company in its most recent Form 13F...

Hennion & Walsh Asset Management Inc. Sells 17,560 Shares of Mirum Pharmaceuticals, Inc. $MIRM

Hennion & Walsh Asset Management Inc. reduced its holdings in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 15.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 98,294 shares of the com...

Tudor Investment Corp ET AL Makes New $2.03 Million Investment in Mirum Pharmaceuticals, Inc. $MIRM

Tudor Investment Corp ET AL acquired a new stake in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 27,654 shares of the compa...

Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target Raised to $125.00

TD Cowen upped their price objective on shares of Mirum Pharmaceuticals from $117.00 to $125.00 and gave the stock a "buy" rating in a research report on Friday...

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.

Current Price	$97.95
Prev Close	$95.86
Open	$96.34
Dividend Yield	0.00%
50-Day Moving Average	$95.37
Beta	0.79
Avg. Volume	1.03M
PE Ratio	-204.87

52-Week High	$109.28
52-Week Low	$38.22
Market Capitalization	$5.91B
EPS (Annual)	-$0.4654
Price to Book	16.15
Revenue Per Employee	$1.4M

MIRM
Mirum Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MIRM News

MIRMMirum Pharmaceuticals Inc